Skip to main content

Novo Holdings A/S's Form 4 filing

Spruce Biosciences, Inc. (SPRB) · filed Mar 25, 2024

Accession no.
0001209191-24-005075
Filed
Mar 25, 2024
Trade date
Mar 21, 2024
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $348.8K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Novo Holdings A/SCIK 000138832510% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 21, 2024COMMON STOCKSSaleDisposed−465,021$0.75−$348,765.752,550,000Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)